Needham & Company Cuts Price Target on Cepheid (CPHD) to $47 Following Pre-Announced 3Q Results
Tweet Send to a Friend
Needham & Company maintained a Buy rating on Cepheid (NASDAQ: CPHD), and cut the price target to $47.00 (from $70.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
